IWP
ABBV icon

IAG Wealth Partners’s AbbVie ABBV Stock Holding History

IAG Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Buy
749
+3
+0.4% +$645 0.02% 129
2026
Q1 		$162K Buy
746
+15
+2% +$3.33K 0.02% 132
2025
Q4 		$167K Buy
731
+3
+0.4% +$683 0.02% 126
2025
Q3 		$169K Sell
728
-421
-37% -$85.7K 0.02% 127
2025
Q2 		$213K Buy
1,149
+4
+0.3% +$743 0.03% 111
2025
Q1 		$240K Sell
1,145
-20
-2% -$3.89K 0.04% 99
2024
Q4 		$207K Sell
1,165
-104
-8% -$19.1K 0.04% 98
2024
Q3 		$251K Buy
1,269
+173
+16% +$32.3K 0.05% 90
2024
Q2 		$188K Sell
1,096
-67
-6% -$11.1K 0.04% 95
2024
Q1 		$212K Buy
1,163
+425
+58% +$73.2K 0.05% 90
2023
Q4 		$114K Sell
738
-73
-9% -$10.6K 0.03% 106
2023
Q3 		$121K Buy
811
+42
+5% +$6.17K 0.03% 98
2023
Q2 		$104K Buy
769
+3
+0.4% +$440 0.03% 113
2023
Q1 		$122K Sell
766
-33
-4% -$5.04K 0.03% 94
2022
Q4 		$129K Sell
799
-42
-5% -$6.44K 0.04% 87
2022
Q3 		$113K Buy
841
+85
+11% +$12.2K 0.04% 85
2022
Q2 		$116K Buy
756
+25
+3% +$3.82K 0.04% 83
2022
Q1 		$118K Buy
731
+41
+6% +$5.96K 0.04% 85
2021
Q4 		$93K Buy
690
+3
+0.4% +$354 0.03% 89
2021
Q3 		$75K Buy
687
+102
+17% +$11.7K 0.03% 95
2021
Q2 		$66K Buy
585
+103
+21% +$11.6K 0.02% 102
2021
Q1 		$53K Buy
482
+2
+0.4% +$214 0.02% 107
2020
Q4 		$52K Buy
480
+2
+0.4% +$192 0.02% 107
2020
Q3 		$42K Buy
478
+186
+64% +$17.5K 0.02% 110
2020
Q2 		$29K Sell
292
-9
-3% -$792 0.01% 131
2020
Q1 		$23K Buy
301
+2
+0.7% +$170 0.02% 134
2019
Q4 		$27K Buy
+299
New +$24.8K 0.02% 153

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IAG Wealth Partners's ABBV Position: Q2 2026 in Review

IAG Wealth Partners increased its AbbVie (ABBV) stake by 0.4% in Q2 2026, buying an estimated $645 and bringing the position to 749 shares worth $189K. The position accounts for 0.02% of the portfolio, ranked #129.

IAG Wealth Partners first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $251K in Q3 2024. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • IAG Wealth Partners held 749 shares of AbbVie worth $189K as of Q2 2026.
  • IAG Wealth Partners bought 3 AbbVie shares in Q2 2026, an estimated $645.
  • AbbVie made up 0.02% of IAG Wealth Partners's portfolio in Q2 2026, its #129 holding.
  • IAG Wealth Partners first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • IAG Wealth Partners's AbbVie position peaked at $251K in Q3 2024.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IAG Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.